Overview

Multicenter Phase 2 Trial: a Tailored Strategy for Locally Advanced Rectal Carcinoma

Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether the tailored management of locally advanced rectal carcinoma can improve the oncologic and functional outcome.
Phase:
Phase 2
Details
Lead Sponsor:
Institut du Cancer de Montpellier - Val d'Aurelle
Treatments:
Capecitabine
Folfirinox